Showing results (511-520 of 726) with videos related to
Sort By:
Pageof 73
American Journal of Surgery|July 26, 2018
Application of 21-gene recurrence score results and ASTRO suitability criteria in breast cancer patients treated with intraoperative radiation therapy (IORT)Barbara S Schwartzberg, Daniel T Chin, Paige L Dorn, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Selective expression rather than specific function of Txk and Itk regulate Th1 and Th2 responsesNisebita Sahu, Ana M Venegas, Dragana Jankovic, et al.The Oncologist|March 13, 2020
Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) ChemotherapyLee Schwartzberg, Rudolph Navari, Rebecca Clark-Snow, et al.Nanoscale|September 14, 2020
Selectively accessing the hotspots of optical nanoantennas by self-aligned dry laser ablationChristian Schäfer, Pradeep N Perera, Florian Laible, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2008
A phase II study of ABT-751 in patients with advanced non-small cell lung cancerAnn M Mauer, Ezra E W Cohen, Patrick C Ma, et al.Science (New York, N.Y.)|April 24, 1999
Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunityE M Schaeffer, J Debnath, G Yap, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2016
NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetronMatti Aapro, Meinolf Karthaus, Lee Schwartzberg, et al.Pancreas|June 16, 2012
The association of rash severity with overall survival: findings from patients receiving erlotinib for pancreatic cancer in the community settingEdward J Stepanski, Carolina Reyes, Mark S Walker, et al.British Journal of Cancer|August 15, 2002
Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapyJ A Glaspy, J S Jadeja, G Justice, et al.British Journal of Haematology|March 29, 2014
Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphomaLee Schwartzberg, Robert Hermann, Ian Flinn, et al.Pageof 73